The second dataset included ROSMAP controls and AD subjects (n = 48) (Mathys et al., 2019), and it showed that PRTN3 was only expressed by excitatory and inhibitory neurons and was downregulated in AD. Here, PRTN3 is linked to Alzheimer disease.